tiprankstipranks
Advertisement
Advertisement
National Health Investors Issues Q4 2025 Supplemental Disclosure
PremiumCompany AnnouncementsNational Health Investors Issues Q4 2025 Supplemental Disclosure
2M ago
National Health Investors Releases Updated Investor Presentation Materials
Premium
Company Announcements
National Health Investors Releases Updated Investor Presentation Materials
2M ago
National Health Investors sees FY26 FFO $4.94-$4.99, consensus $5.12
Premium
The Fly
National Health Investors sees FY26 FFO $4.94-$4.99, consensus $5.12
2M ago
National Health Investors downgraded to Hold from Buy at Deutsche Bank
PremiumThe FlyNational Health Investors downgraded to Hold from Buy at Deutsche Bank
3M ago
National Health Investors price target lowered to $85 from $87 at Cantor Fitzgerald
Premium
The Fly
National Health Investors price target lowered to $85 from $87 at Cantor Fitzgerald
3M ago
National Health Investors Updates Executive Change-in-Control Agreements
Premium
Company Announcements
National Health Investors Updates Executive Change-in-Control Agreements
4M ago
National Health Investors price target raised to $90 from $88 at BofA
PremiumThe FlyNational Health Investors price target raised to $90 from $88 at BofA
5M ago
NHI Earnings Call: Growth Amidst Challenges
Premium
Company Announcements
NHI Earnings Call: Growth Amidst Challenges
5M ago
National Health Investors Reports Strong Q3 2025 Results
Premium
Company Announcements
National Health Investors Reports Strong Q3 2025 Results
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100